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HistoblotSystemic administration of the potassium channel blocker 4-aminopyridine (4-AP) elicits acute convulsions.
Synchronized tonic–clonic activity develops during the first hour after the treatment. However, subsequent
chronic spontaneous seizures do not appear which suggests changes in neuronal excitability. The aim of our
present work was to evaluate alterations in the glutamatergic transmission in the somatosensory cortex of
rats following daily, brief convulsions elicited by 4-AP treatment. Changes in general neuronal excitability
and pharmacological sensitivity of glutamate receptors were tested in ex vivo electrophysiological
experiments on brain slices. In parallel studies quantitative changes in subunit composition of glutamate
receptors were determined with immunohistoblot technique, together with the analysis of kainate induced
Co2+ uptake. The results of our coordinated electrophysiological, receptor-pharmacological and histoblot
studies demonstrated that repeated, daily, short convulsions resulted in a significant decrease of the general
excitability of the somatosensory cortex together with changes in ionotropic glutamate receptor subunits.
The relative inhibitory effect of the AMPA receptor antagonist, however, did not change. The NMDA receptor
antagonist exerted somewhat stronger effect in the slices from convulsing animals. 4-AP pretreatment
resulted in the attenuation of kainate induced Co2+ uptake, which suggests either reduction in non-NMDA
receptors numbers or reduction in their Ca2+ permeability. Repeated seizures decreased GluR1–4 AMPA
receptor subunit levels in all cortical layers with a relaitve increase in GluR1 subunits. While the principle
NR1 NMDA receptor subunit showed no significant change, the staining density of NR2A subunit increased.
These changes in ionotropic glutamate receptors are consistent with reduced excitability at glutamatergic
synapses following repeated 4-AP induced seizures.© 2009 Elsevier Inc. All rights reserved.IntroductionChemical convulsants like kainate (KA), pilocarpine (PILO),
pentylenetetrazol (PTZ), bicuculline (BIC) or N-methyl-D-aspartate
(NMDA) are regularly used to evoke highly synchronized electrical
brain discharges which are accompanied by characteristic epilepti-
form behavioural symptoms (Turski et al., 1984; Singh et al., 1991;
Cavalheiro, 1995; Nehlig and Pereira 1996; Steriade et al., 1998).
Treatment of living animals with these convulsants may elicit
spontaneous epileptic activity. A single dose of KA or PILO application
results in typical tonic–clonic seizure activity and status epilepticus in
the acute period, which is followed by a 3–10 week latency phase, and
a subsequent epileptic period, with typical spontaneous tonic–clonic
seizure discharges. These chronically epileptic animals are character-
ized by significant neuronal loss, astrocyte proliferation, sprouting of
axon collaterals and synaptic reorganization (Mello et al., 1993;ll rights reserved.Cavalheiro,1995; Dubé et al., 2000; Medvedev et al., 2000). The effects
of BIC or PTZ are less damaging, the treated animals develop
generalized spike and wave activity which is maintained for a long
period (Neckelmann et al., 1998., Klioueva et al., 2001). Repeated
subthreshold application of convulsants, e.g. glutamate, may also
result in enhanced synaptic sensitivity according to the kindling
model (McNamara et al., 1993). These epileptic discharges are
successfully blocked by different glutamate receptor (GluR) antago-
nists, however, the susceptibility for specific NMDA or AMPA receptor
antagonists are different (Berg et al., 1993; Dóczi et al., 1999; Szabados
et al. 2001; Gulyás-Kovács et al. 2002).
Systemic administration of a single dose of the potassium channel
blocker 4-aminopyridine (4-AP) also elicits acute convulsions (Mihály
et al., 1990). On the EEG synchronized tonic–clonic seizures develop
during the first hour after the treatment. 4-AP applied intraperitone-
ally in 5 mg/kg dose provokes hyperexcitability, tremor, head
nodding, forepaw tremor, sniffing, salivation, chewing and myoclonus
(Fragozo-Veloz and Tapia, 1992; Mihály et al., 2005). Generally one,
sometimes two seizure episodes appear, and animals generally
recover in 2–4 h following the application of the drug (Fragoso-
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showed that 4-AP stimulates cortical layers differently, and character-
istic activity pattern develops following treatment (Versteeg et al.,
1995; Borbély et al., 2006). Ionotropic GluR antagonists effectively
block the spontaneous seizures in the middle and deep layers but not
in the superficial layer (Yang and Benardo, 2002). Although
subsequent chronic spontaneous seizures do not appear as a
consequence of repeated application of 4-AP, effects on the
excitability and sensitivity of the brain could be supposed. Our
parallel hippocampal studies indicated rearrangement of GluR
subunits following repeated 4-AP injections (Borbély et al., 2009).
The aim of the present series of experiments was to investigate the
influence of repetitive, short convulsions on the somatosensory cortex
in rats. Changes in general neuronal excitability and pharmacological
sensitivity of AMPA and NMDA receptors to antagonists were tested in
ex vivo electrophysiological experiments on brain slices. In parallel
studies quantitative changes in AMPA and NMDA receptor subunit
proteins were determined with immunohistoblot technique, together
with the analysis of kainate induced Co2+ uptake through activated
non-NMDA receptors.
Materials and methods
Experiments were performed on horizontal plain slices of
somatosensory cortex prepared from adult, male Wistar rats (150–
280 g, Charles Rivers, Budapest, Hungary). The experimental design
had been approved by the Animal Care Committees of universities and
by the Budapest- and Szeged Animal Health Care Authorities. Rats
were kept under constant 12 h light/dark cycle and controlled
temperature (22±2 °C). Standard pellet food and tap water wereFig.1. (A) The schematic diagram indicates the site of recording (lower part of layer 3 of the so
recording electrode at the border of thewhite and greymatters (modified fromPaxinos andW
electrical simulation. The first part (N0) of the early negative wave corresponded to the incom
possible to distinguish as a separate peak; usually it only appears as a small deflection on the
evoked responseswere characterized by the peak-to-peak amplitude of the early (N1–P1) and
demonstrates that both (N1–P1) and (P1–N2) peaks are effectively lessened by the mixtureavailable ad libitum. All chemicals were purchased from Sigma if not
stated otherwise. GYKI 52466 was the kind gift of I. Tarnawa.
Treatment of animals
4-AP was dissolved in physiological saline and injected every day
intraperitoneally for 12 consecutive days. The starting dose was
4.5 mg/bwkg. If rats failed to produce stage 5 seizure according to the
Racine-type scale (Racine, 1972), the dose was increased by 5%, and it
was further increased by 5% steps if stage 5 seizure failed to develop
on the previous day. The maximal dose was 6.65 mg/bwkg. Control
rats received daily physiological intraperitoneally for 12 days.
Slice preparation and electrophysiological recording
Electrophysiological recordings were carried out on 64 slices from
18 rats. Animals were decapitated in deep chloral-hydrate anesthesia
(350 mg/bwkg), the brain was quickly removed and horizontal slices
(400 μm thick) containing the somatosensory cortex and the
hippocampus were cut by a vibratome (Fig. 1A). After 1 h regeneration
in the incubation solution containing HEPES-buffer (N-2-hydro-
xyethylpiperazine-N′-2-ethanesulfonic acid (6.7 mM) and its sodium
salt (2.6 mM), pH: 7.1–7.2) slices were transferred to a Haas-type
recording chamber (Experimetria, Budapest, Hungary) throughwhich
standard artificial cerebrospinal solution (ACSF) was perfused
(1.5 ml/min) using a peristaltic pump (Heidolph PD 5101). The
solution was saturated with carbogene (5% CO2–95% O2) at 33±1 °C.
The composition of this standard perfusion ACSF solution was
(in mM): 126 NaCl; 26 NaHCO3; 1.8 KCl; 1.25 KH2PO4; 1.3 MgSO4;
2.4 CaCl2; 10 glucose.matosensory cortex) and the position of the bipolar stimulation electrode right below the
atson,1982). S2: the somatosensory area. (B) Original record of field response evoked by
ing action potentials, which was followed by a synaptic (N1) peak. N0 is frequently not
leading edge of the potential. P1 the first positive and N2 the second negative peaks. The
late (P1–N2) components. (C) Original recordof evokedfield response (grey line)which
of 40 μM GYKI 52466 and 25 μM APV after 30 min incubation (black line).
Fig. 2. Schedule of different treatments during the recordings from slices. –15means the
beginning of the incubation of slices in the recording chamber when continuous test
stimulation was applied. Basic activity was recorded at 0 min, and than at half of the
slices the perfusion solution was switched to glutamate antagonist containing solution.
R: recording points, when I–O curves and average of 10 evoked responses (aER) at 2 T
stimulation intensity were recorded. Ts: test stimulation at 2 T stimulus intensity with
0.05 Hz frequency.
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positioned as recording electrodes into the lower part of layer III of the
somatosensory cortex, while bipolar tungsten stimulating electrodes
were positioned right below the recording electrodes at the border of
the white and grey matter. Duration of the stimulation square voltage
pulses was 100 μs and the amplitude was gradually varied between
threshold and supramaximal values. Signals were amplified with an
Axoclamp 2A amplifier (Axon Instruments Inc., Union City, CA), A/D
converted and recorded with the SPEL Advanced Intrasys computer
program (Experimetria Ltd., Budapest, Hungary).Fig. 3. Alterations of basic excitability in the somatosensory cortex slices after the 12-da
P1) components of the evoked response and (B) changes of the amplitude of the late (P1
Continuous 10 min test stimulation at 2 T stimulus intensity resulted in changes of amplit
was enhanced. However, 4-AP pretreatment lessened the amplitude of the evoked respon
the P1–N2 component. (T means the stimulus threshold of evoked response. ⁎ symbol
pb0.001).The viability of each slice was tested at the beginning of the pro-
cedure. Single-shock stimulation evoked a characteristic field res-
ponse, which consists of an early and a late component (Fig. 1B). In
accordance with the analysis of Abbes et al. (1991) and Hodgson et al.
(2005) the first part (N0) of the early negative wave corresponded to
the incoming action potentials, which was followed by a synaptic (N1)
peak. Average latencies of N0 and N1 peaks were 3.7 ms and 6.1 ms,
respectively. N1 usually was of higher amplitude compared to N0. In
our experiments N0 was not always possible to distinguish as a
separate peak; usually it only appeared as a small deflection on the
leading edge of the potential. The early negative component was
followed by a positive (P1) peak and theywere effectively inhibited by
the mixture of GYKI 52466 and APV (Fig. 1C).
If the peak-to-peak amplitude of the maximal evoked response
(N1–P1) was smaller than 1 mV, the slice was not used for further
experiments. Slices were continuously stimulated with medium-
strength stimuli at a rate of 0.05 Hz.15 min after placing the slices into
the recording chamber the stimulus threshold (T) was determined.
Then input–output (I–O) curve was recorded when gradually
increasing the stimulus intensity from T to 4 T in 6 steps. Response
amplitudes were plotted against intensities, and than an average of 10
evoked responses (aER) at 2 T stimulation intensity was recorded. At
each stimulus intensity mean amplitude value were calculated from
three evoked responses. Subsequently, 0.05 Hz continuous stimula-
tion was applied with 2 T if not specified otherwise, so called test
response (TS) evoked at this stimulation intensity were calculated as ay-long 4-AP pretreatment. (A) Changes in peak-to-peak amplitude of the early (N1–
–N2) component against the gradually increasing stimulus intensity are represented.
ude of evoked response (aER). (C) After 30 min of a 0.05 Hz, stimulation this increase
se in all experimental groups. (D) The 4-AP pretreatment had no detectable effect on
indicates significant differences at pb0.05, while ⁎⁎ means pb0.01, and ⁎⁎⁎ means
Fig. 4. Effect of AMPA receptor antagonist GYKI 52466 on the amplitude of early (N1–P1) component of the evoked response (aER) in control (A) and 4-AP pretreated (B) slices.
Columns demonstrate significant inhibition at 2 T stimulus intensity in both groups, the effects were, however, more enhanced in the control group. Graphs demonstrate original
records. C and D show the whole stimulus intensity-evoked response (I–O) curves. T means the stimulus threshold of evoked response. ⁎ symbol indicates significant differences at
pb0.05, while ⁎⁎ means pb0.01.
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different protocols were followed (Fig. 2). To test the altered basic
excitability following chronic 4-AP treatment no special treatment
was applied apart from the continuous low frequency stimulation. To
analyze pharmacological sensitivity of particular GluRs, standard
perfusion solution was switched either to AMPA receptor antagonist
containing solution (40 μM GYKI 52466; 1-(aminophenyl)-4-methyl-
7,8 methylendioxy-5H-2,3-benzodiazepine), or to NMDA receptor
antagonist containing solution (25 μM D-APV; D-2-amino-5-phospho-
nopentanoic acid). Recordings were finished by determination of test
responses and I–O curves (Figs. 2A, B). Each experimental group
contained 8–8 independent records.
Recorded datawere analyzed also with the SPEL Advanced Intrasys
computer program (Experimetria Ltd., Budapest, Hungary). The short
latency, early component was characterized by the peak-to-peak
amplitude of N1–P1 waves. The longer latency, late component was
characterized by the peak-to-peak amplitude of the P1 and the second
negative (N2) component (Fig. 1B).
Statistical analysis
To compare control and treated groups, in each series of expe-
riments one-way ANOVA was performed followed by Newman–Keuls
post hoc test (pb0.05). Homogeneity of variances and normal
distribution of data were tested before statistical analysis. Data were
presented as mean±S.E.M.Cobalt-uptake determination
Slices were obtained form nine control and ten 4-AP treated
animals to test alterations in Co2+ uptake. Slice preparation was
carried out in the same way as described for electrophysiological
recordings. The thickness of the slices was, however, 250 μm. From
each rat 8–10 horizontal slices containing the somatosensory cortex
slices were stained and evaluated. The procedure was performed as
described previously (Pruss et al., 1991). Briefly, slices were incubated
in a Ca2+ free incubation solution for 5 min before placement into an
uptake buffer (13 mM sucrose, 57.5 mM NaCl, 5 mM KCl, 2 mM
MgCl2, 1 mM CaCl2, 12 mM glucose, 10 mM HEPES) supplemented
with 5mMCoCl2 and 100 μMKA. Incubation lasted for 20min at room
temperature (∼20 °C). Slices incubated in the same solution without
KA served as background controls. After the stimulated Co2+ uptake,
slices were rinsed once in the uptake buffer and incubated in the same
buffer containing 2 mM EDTA to remove non-specifically bound Co2+.
Following that, slices were rinsed twice with the uptake buffer, and
Co2+ was precipitated by incubation in a 0.12% (NH4)2S solution for
5 min. During this procedure, dark CoS precipitate was formed in the
cells. At the end, slices were fixed in 4% paraformaldehyde for 30 min
andmounted into glycerin for image analysis. Co2+ stained sliceswere
analyzed by an Olympus CH-2 microscope equipped with an Olympus
Camedia C4040-Zoom digital camera connected to a PC running an
AnalySIS 3.2 Docu (Soft Imaging System) software. Pictures were
digitized at a 4-fold magnification and converted to 8-bit grey scale
Fig. 5. Effect of NMDA receptor antagonist APV on the amplitude of the late (P1–N2) component of the evoked response (aER) in control (A) and in 4-AP pretreated (B) slices.
Columns demonstrate the effects at 2 T stimulus intensity in both groups, the effects was, however, slightly enhanced in the control group. Graphs demonstrate original records. C and
D show thewhole stimulus intensity-evoked response (I–O) curves. Tmeans the stimulus threshold of evoked response. ⁎ symbol indicates significant differences at pb0.05, while ⁎⁎
means pb0.01, and ⁎⁎⁎ means pb0.001.
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taken between the I. cortical layer and the corpus callosum. According
to the thickness of the cortical region each recorded area was 50 pixel
thick and 300–600 long. Staining intensity was measured in arbitrary
units; one data point corresponded to the mean of 50 recorded points.
Optical density (OD) of a 50×100 pixel area in the corpus callosum
was determined in each slide as background and data were always
corrected with this OD value. In all series of experiments the corrected
OD values of untreated slices were subtracted from the corrected OD
values of KA stimulated slices. Parallel control and 4-AP treated slices
were compared. For this comparison the distance between the pial
surface and the corpus callosum was divided to 20 equal divisions,
which were correlated to cortical layers on the basis data of Skoglund
et al. (1996). The borders of each layer (L) were as follows: LI: 1.
division, LII: 2–3 division, LIII: 4–6 division, LIV: 7–8 division, LV: 9–13
division, LVI: 14–20 division.
Histoblot analysis of ionotropic glutamate receptor proteins
Rats were sacrificed on the day following the final 4-AP treatment,
and used to determine changes in the distribution of different AMPA
and NMDA type GluR subunit proteins, using an in situ blotting
technique (Tonnes et al. 1999; Gallyas et al. 2003; Kopniczky et al.,
2005). In brief, animals were deeply anesthetized with diethyl ether,
decapitated and the brains were quickly frozen in isopentane and
stored at−80 °C until sectioning. Horizontal cryostat sections (10 μm)
were apposed to nitrocellulose membranes, which were previouslymoistened with 48 mM Tris-base, 39 mM glycine, 2% (w/v) SDS and
20% (w/v) methanol for 15 min at room temperature (∼20 °C). After
blocking in 5% (w/v) non-fat dry milk in PBS, nitrocellulose
membranes were DNase I-treated (5 U/ml), washed and incubated
in 2% (w/v) SDS,100mM β-mercaptoethanol in 100mM Tris–HCl (pH
7.0), for 60 min at 45 °C to remove adhering tissue residues. After
excessive washing, blots were reacted with affinity-purified subunit
specific antibodies (0.5 μg/ml) in blocking solution overnight, at 4 °C.
The following primary antibodies were used: anti-GluR1; anti-GluR2
(Chemicon; 1 μg/ml); anti-GluR1-4 (pan-AMPA, Pickard et al. 2000),
anti-NR1 (Pharmingen; 2 μg/ml); anti-NR2A (Chemicon; 1 μg/ml);
anti-KA-2 (Upstate; 1:500). The bound primary antibodies were
detected with alkaline phosphatase-conjugated anti-rabbit IgG sec-
ondary antibody (Tonnes et al. 1999). To facilitate the identification of
structures and cell layers, adjacent cryostat sectionswere stainedwith
cresyl violet. Digital images were acquired by scanning the mem-
branes using a desktop scanner, data were stored as grey scale images.
Evaluation of images was carried out according to method described
at cobalt-uptake determination.
Results
Seizure behaviour
The i.p. administration of 4-AP induced generalised tonic–clonic
seizures. In average, one or two seizures were detected following the
convulsant application. The average latency of the first seizure was
141I. Világi et al. / Experimental Neurology 219 (2009) 136–14526.6±5.4 min. This event was frequently followed by a second fit
within the first hour after the convulsant treatment. The mean delay
between the two seizure activities was 16.2±4.9 min.
General neuronal excitability
Results show a general decrease in excitability following chronic 4-
AP pretreatment. The basic I–O curves (Fig. 3A) demonstrate that the
mean amplitude of the early component is reduced compared to
control slices. At 2 Tstimulus intensity the aERwas 1.8±0.08mV in the
control v.s. 1.4±0.08 mV in the 4-AP pretreated slices. Following test
stimulation without any treatment the amplitude increased in both
experimental groups, but it remained significantly smaller in the 4-AP
pretreated slices. After 10 min the amplitudes were 2.46±0.19 mV
(136.6%) vs. 1.66±0.19 mV (115.3%), while after 30 min they were
2.97±0.19 mV (165.0%) vs. 1.94±0.26 mV (138.6%) (Fig. 3C). The lateFig. 6. The effect of the 4-AP pretreatment on KA induced Co2+ uptake in different layers of th
4-AP pretreated (c, d) slices, a and c panels represent the background activity, while b and d
(OD) between background and KA treated slices were calculated along the cortex, perp
demonstrated on (B) part of the figure. I–VI represent the proper cortical layers. Overall Co
indicates significant differences at pb0.05.component did not always appear in the control slices or its
amplitude was very small (0.46±0.06 mV), which was the same
(0.47±0.04 mV) in the 4-AP pretreated slices (Fig. 3B). After 10 min
incubation it was 0.45±0.95 mV and 0.41±0.09 mV, and after
30 min incubation it reached 0.58±0.14 mV and 0.60±0.09 mV,
respectively (Fig. 3D).
Pharmacological sensitivity to AMPA and NMDA receptor antagonists
Application of GluR antagonists into the perfusion solution
effectively reduced the amplitude of the evoked responses. The
mixture of GYKI 52466 and APV lessened the amplitude of all
components, the most sensitive part was the P1 wave. The diminish of
N1–P1 peak was 81±6.1% following the application of 40 μM GYKI
52466 together with 25 μMAPV for 30min (Fig.1C). Application of the
AMPA receptor antagonist GYKI 52466 alone for 30 min into thee sensory cortex. (A) Figures show the original records from control (a, b) and from the
panels represent samples following KA treatment. The difference of the optical density
endicular to the pial surface and the corpus callosum. These differences in OD are
2+ uptake of the 4-AP pretreated slices is reduced compare to control slices. ⁎ symbol
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both in the control and in the 4-AP pretreated slices (Fig. 4). The
relative effectiveness of the inhibitor on the N1–P1 peak was smaller
in the 4-AP pretreated group. In the control slices, the amplitude of the
evoked response at 2 T stimulus intensity was 105.9±7.1% of the basic
maximal amplitude. In the presence of GYKI 52466 the relative value
was only 65.4±5.5%. In 4-AP pretreated slices the amplitude at 2 T
stimulus intensity was 91.5±11.4% of the basic maximal amplitude,
and in the presence of GYKI 52466 it reached 46.7±5.4%.
The NMDA receptor antagonist APV reduced the amplitude of the
early and the late component of the evoked responses (Fig. 5), and
typically decreased the P1–N2 wave. While the relative amplitude
value was 92.2±7.3% in the control and 102.6±8.8% in the 4-AP
pretreated slices after 10 min incubation in normal ACSF, in the
presence of APV the amplitude values reached 67.3±17.8% in the
control and 70.2±12.8% in the 4-AP pretreated slices.
Modification in Co2+ uptake through AMPA/KA receptors
KA effectively activates non-NMDA receptors and Co2+ can cross
the plasma membrane through Ca2+ permeable ionotropic GluR
channels. The difference in the optical densities (OD) between
background and KA treated slices was used to estimate the abundance
of Ca2+ permeable AMPA/KA receptor population in sensory cortical
regions. Overall, OD associated with Co2+ uptake along the cortex
calculated perpendicular to the pial surface and the corpus callosum
was higher in control slices than in slices obtained from 4-AP treated
rats (Fig. 6), the mean alteration was 39±14%. These differencesFig. 7. 4-AP treatment induced differential changes in ionotropic GluR subunit densities. T
highlighted in grey correspond to the regions where changes in optical density were measu
recording electrodes were positioned in the electrophysiological experiments. Graphs show
pretreatment. ⁎pb0.05 level, ⁎⁎pb0.01, ⁎⁎⁎pb0.005. The number of independently tested b
GluR1–4: 24; GluR1flop: 24; GluR2: 20; KA-2: 36.appeared in each layer of the somatosensory cortex, which indicated a
significant reduction in the density of functional, Ca2+ permeable
AMPA/KA receptors in 4-AP pretreated slices.
Alteration in glutamate receptor subunit densities
To complement the functional studies, histoblot analysis was per-
formed to investigate changes in ionotropic GluR subunit protein
levels in different cortical layers. Pooled data is illustrated on Fig. 7 and
in the text below we indicate % changes in cortical layer III, where the
recording electrodes were positioned in the electrophysiological
experiments. Changes in total AMPA receptor expression levels were
investigated with a polyclonal antibody recognizing the conserved
extracellular loop region of all four AMPA receptor subunits (GluR1–4,
both flip and flop; Pickard et al., 2000). GluR1–4 levels decreased in all
cortical layers (89±2% in layer III), which is consistent with reduced
glutamatergic transmission established in our functional studies
(Fig. 7). To identify differential changes in individual AMPA receptor
subunit proteins, we performed additional experiments with GluR1
and GluR2 selective immunoreagents. The relative density of GluR1
AMPA receptor subunit protein increased significantly in layers III
(113±9%). The density of GluR2 subunit was not altered in layers I–V
of the somatosensory cortex. However, a small but significant reduc-
tion in GluR2 immunoreactivity was detected in deeper segments of
layer VI (Fig. 7). Due to the lack of sufficiently specific GluR3 antibody,
we were unable to establish changes in the expression level of this
subunit. The expression level of GluR4 is low in the cerebral cortex
throughout development (Molnar, 2008) therefore it is unlikely thathe picture represents part of the somatosensory cortex following Nissl staining. Areas
red in immunostained histoblots. The light grey cube symbolizes the place where the
the densities of different ionotropic GluR subunit proteins after the 12-day-long 4-AP
rain sections (the “n” values) are as follows: NR1: 24; NR2a: 24; NR2b: 20; GluR1: 26;
143I. Világi et al. / Experimental Neurology 219 (2009) 136–145this subunit plays a significant role. Concerning the NMDA receptor
subunits, there was a moderate reduction in NR1 subunit densities
(91±4% in layer III), but it was not significant. On the other hand,
there was an increase in NR2A expression levels in layers III (109
±3%). There were no detectable changes in KA-2 KA receptor
densities in brain samples obtained from 4-AP treated rats (96±3%
in layer III). In summary, the histoblot analysis indicates significant
changes in ionotropic GluR proteins which include a prominent down-
regulation of total AMPA receptors in all cortical regions and
differential changes in AMPA and NMDA receptor subunits which
may alter their subunit composition in different cortical layers.
Discussion
The aim of our present work was to evaluate alterations in the
glutamatergic transmission following daily, brief convulsions elicited
by 4-AP treatment. The results of our coordinated electrophysiologi-
cal, receptor-pharmacological and histoblot studies demonstrated
that repeated convulsions for 12 days result in a significant decrease of
the excitability of the somatosensory cortex together with the
rearrangement of AMPA and NMDA receptor subunits. The general
excitability of the somatosensory cortex decreased, the mean ampli-
tude of the field potentials evoked by electrical stimulation was
significantly smaller after the 4-AP pretreatment compared to the
control. The relative inhibitory effect of the AMPA receptor antagonist
GYKI 52466, however, did not change after the treatment. The NMDA
receptor antagonist APV exerted somewhat stronger effect in the
slices from convulsing animals. 4-AP pretreatment resulted in the
attenuation of KA induced Co2+ uptake, which suggests either
reduction in the number of non-NMDA receptors or reduction in
their Ca2+ permeability. Repeated seizures resulted in a decrease in
the immunoreactivity of GluR1–4 AMPA receptor subunits in all
cortical layers, while the density of the GluR1 subunit increased in
outer layers of the cortex. As to the NMDA receptor subunits, the
staining density of NR2A increased without significant change in NR1
protein expression.
In the majority of vertebrate central nervous systems ionotropic
glutamate receptor channels mediate fast excitatory synaptic
responses (Dingledine et al., 1999, Mayer, 2005). Several experimental
data show that electrical stimulation or application of different
chemical convulsants result in alteration of synaptic efficacy (Barnes
and Pinel, 2001; Rejdak et al., 2001; Addae et al., 2007). Depending on
the characteristics and intensity of stimulation synaptic adaptations
can develop to different directions. On one hand, neuroprotective
processes may initiate and brain tolerance develops, or on the other
hand following the severe over-excitation neuronal degeneration may
emerge. Changes in GluR characteristics are often detected subse-
quent to seizures or other neuronal injuries (Michaelis, 1998; Világi
et al., 1999). Application of repeated mild electrical stimulation elicits
generalized tonic–clonic seizures. The underlying molecular and
cellular processes are not fully understood, but it was shown, that
synaptic efficacy increases and neuronal networks reorganize in this
epilepsy model (Morimoto et al., 2004). Large dose of intraperitoneal
or cerebroventricular KA exposure also results in development of
severe seizure. It is proven that following these serious insults the
subunit composition of non-NMDA GluRs change (Grooms et al.,
2000; Jia et al., 2006), which may lead to increased Ca2+ influx into
activated neurons. Ca2+-triggered excitotoxic processes may be
initiated, which either result in local rearrangements at synapses or
induction of cell death (Stone and Addae, 2002; Liu and Zukin, 2007).
Glial and neuronal glutamate transporters play important role in the
regulation of extracellular glutamate level. Alteration in transporter
function may also be noticed during convulsions (Furuta et al., 2003;
Campbell and Hablitz, 2008). In addition to excitotoxicity, neuropro-
tective processes may also be triggered by increased synaptic activity
in seizures (Mattson, 2007).4-AP is a commonly used convulsant. It selectively blocks some
types of voltage gated K+ channels (Thompson, 1982; Den Hertog
et al., 1987; Kiss et al., 2002), which cause neuronal depolarization
and facilitate Ca2+ influx into presynaptic terminals enhancing the
transmitter release (Thesleff, 1980; Qian and Saggau, 1999; Hu et al.,
2001; Gu et al., 2004). As the ratio of the excitatory glutamatergic
transmission in the neocortex is very high (Rubenstein and
Merzenich, 2003), following 4-AP application epileptiform seizure
develops as cortical activity is pushed toward excitation (Szente and
Baranyi 1987; Fragozo-Veloz et al., 1990). However, acute seizure
initiated by 4-AP is not followed by spontaneous recurrent seizures in
the chronic phase. Although some data point to receptor reorganiza-
tion, major structural or biochemical rearrangements were not
detected following long lasting 4-AP application (Vizi et al., 2004).
Our electrophysiological results show that seizure activity, evoked
by repeated daily application of 4-AP, triggers neuroprotective
mechanisms in the somatosensory cortex diminishing basic excit-
ability. High amount of glutamate released into the extracellular space
during seizures may initiate these neuronal protective processes, i.e.
AMPA receptor desensitization or internalization (Greger and Esteban,
2007), which might result in the decreased excitability. It was also
recently reported that neuroprotective processes may be initiated
through NMDA receptor activation, application of mild convulsant
preconditioning stimuli results in neuronal tolerance and attenuates
the effects of further serious insults (Rejdak et al., 2001). It is also
proved that following epileptic seizures or other brain injuries the
concentration of endogenous kynurenic acid increase. Kynurenic acid
appears to be released by glial cells and protects neurons by
antagonizing the activation of ionotropic Glu receptors (Wu and
Schwartz, 1996; Scharfman et al., 1999). These processes may cause
the reduction of peak-to-peak amplitude of the early (N1–P1)
component of the electrically evoked field potential in slices from
pretreated animals. Normally these parts of the excitatory field
potential are the largest in layer III of the somatosensory cortical
slices and develop with characteristic latency as a consequence of
synaptic activation of neurons in the recorded layer (Abbes et al.,
1991). As non-NMDA receptor activation plays a crucial role in the
development of the early component of the evoked response (Conti
and Weinberg, 1999), reduced amplitude to be seen in I–O curve of
pretreated slices refer to retarded AMPA receptor activity. The AMPA
receptor antagonist GYKI 52466 (Tarnawa et al., 1990) effectively
inhibited the evoked response also in the pretreated slices showing
that AMPA receptors were not fully suppressed. In the background of
the reduced excitability theremight be a decrease in the sensitivity- or
a reduction in number of active AMPA receptors. The overall Co2+-
uptake activated by KA was also depressed in all layers, while the
characteristic pattern of the laminar receptor distribution (Zilles et al.,
1999) did not change. So we can conclude that the number of
functional non-NMDA receptors in the postsynaptic membrane
decreased. Strong activation during the epileptic seizures may drive
internalization of AMPA receptors, and repetitive stimulation may
initiate metabolic processes to depress the synaptic efficacy (Lüscher
and Frerking, 2001). Results of our histoblot studies also support this
notion. Decrease in the amount of GluR1–4 subunits in all cortical
layers is consistent with the reduced basic excitability and the
lessening of the amplitude of early component of filed potential.
Differential changes in relative expression levels of GluR1, GluR2
AMPA receptor and NR1, NR2A NMDA receptor subunits in some of the
cortical layers suggest 4-AP treatment induced subunit rearrange-
ments in ionotropic GluRs. It is possible that the relative increase in
NR2A subunit containing NMDA receptors also contribute to the
depression of glutamatergic synaptic transmission (Schotanus and
Chergui, 2008).
The same treatment may evoke dissimilar responses in different
brain regions which can lead to either sensitization or depression.
These plastic changes may depend on the characteristic function of
144 I. Világi et al. / Experimental Neurology 219 (2009) 136–145the investigated area. On the basis of our experiments, we can
conclude that in the somatosensory cortex over-excitation may
initiate tolerance, which can guarantee the protection of this
functionally highly significant brain region from extensive damage.
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